Target intelligence / Profile preview

Novel transcript, antisense to NPIPA3

Molecular classification
Other (Non-coding RNA)
01

Overview

ENSG00000305462 refers to a non-coding RNA gene named *novel transcript, antisense to NPIPA3*. It is located antisense to the NPIPA3 locus, which encodes Nuclear Pore Complex Interacting Protein Family Member A3. No protein product is described for this transcript, and no functional characterization, disease relevance, or therapeutic targeting is reported in current genomic databases. Its inclusion in target lists may be due to incomplete annotation or misclassification, as it lacks properties of canonical drug targets such as receptors, enzymes, or transporters. GeneCards and other gene databases recognize ENSG00000305462 as an "RNA Gene" without protein-coding capacity or established function. Antisense transcripts are often annotated in reference genomes, but many lack functional validation or therapeutic significance unless experimentally demonstrated. The relationship to NPIPA3 (a genuine protein-coding gene) is purely positional and does not impart target status. There is no evidence for involvement in signaling, regulation, disease mechanisms, or drug interaction. The protein-coding gene in the region, NPIPA3 (Nuclear pore complex interacting protein family member A3), is distinct and not described as a major therapeutic target. This transcript should not be considered a druggable entity or a classic biological target category. Its listing may stem from genome annotation artifacts or incomplete data, and it does not meet the criteria for structured target curation.

Other names
ENSG00000305462novel transcript antisense to NPIPA3antisense NPIPA3 RNA

Beyond the preview

Go deeper on Novel transcript, antisense to NPIPA3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to NPIPA3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call